PHASE 2B TRIAL TO EVALUATE THE SAFETY AND FACTOR IX LEVELS RESULTING FROM A DAILY SUBCUTANEOUS PROPHYLAXIS TREATMENT REGIMEN OF DALCINONACOG ALFA (DALCA) IN HEMOPHILIA B
HAEMOPHILIA(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
HAEMOPHILIA(2020)